Sara Elizabeth Arian, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Embryo Implantation | 3 | 2024 | 270 | 1.710 |
Why?
|
Fertilization in Vitro | 6 | 2024 | 1292 | 1.180 |
Why?
|
Embryo Transfer | 4 | 2023 | 522 | 0.960 |
Why?
|
Endometrium | 2 | 2024 | 403 | 0.930 |
Why?
|
Infertility, Female | 4 | 2024 | 760 | 0.700 |
Why?
|
Reproductive Techniques, Assisted | 4 | 2021 | 497 | 0.700 |
Why?
|
Ovulation Induction | 1 | 2021 | 277 | 0.650 |
Why?
|
Cryopreservation | 3 | 2021 | 728 | 0.640 |
Why?
|
Preimplantation Diagnosis | 1 | 2020 | 143 | 0.610 |
Why?
|
Abortion, Spontaneous | 1 | 2022 | 533 | 0.580 |
Why?
|
Uterus | 3 | 2017 | 649 | 0.540 |
Why?
|
Ovary | 2 | 2021 | 959 | 0.540 |
Why?
|
Anemia, Aplastic | 1 | 2018 | 230 | 0.520 |
Why?
|
Peritoneum | 1 | 2017 | 225 | 0.520 |
Why?
|
Therapies, Investigational | 1 | 2016 | 111 | 0.510 |
Why?
|
Ovariectomy | 1 | 2018 | 614 | 0.510 |
Why?
|
Oocytes | 1 | 2020 | 1166 | 0.510 |
Why?
|
Embryonic Development | 1 | 2020 | 721 | 0.510 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 1135 | 0.490 |
Why?
|
Prenatal Diagnosis | 1 | 2020 | 1265 | 0.420 |
Why?
|
Fertility | 1 | 2017 | 771 | 0.400 |
Why?
|
Infertility | 1 | 2017 | 654 | 0.350 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2898 | 0.340 |
Why?
|
Pregnancy | 15 | 2024 | 29874 | 0.340 |
Why?
|
Pregnancy Rate | 2 | 2023 | 648 | 0.330 |
Why?
|
Placenta Previa | 2 | 2021 | 122 | 0.320 |
Why?
|
Rectal Neoplasms | 1 | 2017 | 1157 | 0.300 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.280 |
Why?
|
Placenta Accreta | 2 | 2021 | 237 | 0.280 |
Why?
|
Laparoscopy | 1 | 2017 | 2035 | 0.250 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3205 | 0.210 |
Why?
|
Review Literature as Topic | 1 | 2024 | 348 | 0.200 |
Why?
|
Superovulation | 1 | 2020 | 11 | 0.190 |
Why?
|
DNA Fragmentation | 1 | 2020 | 237 | 0.170 |
Why?
|
Fertilization | 1 | 2021 | 199 | 0.170 |
Why?
|
Embryo Culture Techniques | 1 | 2020 | 84 | 0.170 |
Why?
|
Pregnancy Outcome | 3 | 2020 | 2921 | 0.170 |
Why?
|
Live Birth | 1 | 2022 | 511 | 0.160 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2022 | 2151 | 0.160 |
Why?
|
Fibromyalgia | 1 | 2022 | 405 | 0.150 |
Why?
|
Female | 24 | 2024 | 392644 | 0.150 |
Why?
|
Treatment Failure | 1 | 2024 | 2645 | 0.150 |
Why?
|
Maternal Age | 2 | 2017 | 809 | 0.150 |
Why?
|
Blastocyst | 1 | 2020 | 433 | 0.140 |
Why?
|
Maternal Mortality | 1 | 2020 | 302 | 0.140 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2017 | 34 | 0.140 |
Why?
|
Aneuploidy | 1 | 2020 | 551 | 0.130 |
Why?
|
Mullerian Ducts | 1 | 2017 | 203 | 0.130 |
Why?
|
Hormone Antagonists | 1 | 2016 | 107 | 0.130 |
Why?
|
Pregnancy Trimester, First | 1 | 2020 | 907 | 0.130 |
Why?
|
Retrospective Studies | 7 | 2023 | 80636 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2016 | 118 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2021 | 768 | 0.110 |
Why?
|
Fallopian Tubes | 1 | 2014 | 177 | 0.110 |
Why?
|
Cancer Care Facilities | 1 | 2016 | 422 | 0.110 |
Why?
|
Humans | 23 | 2024 | 761504 | 0.100 |
Why?
|
Plant Extracts | 1 | 2016 | 498 | 0.100 |
Why?
|
Aromatase Inhibitors | 1 | 2016 | 513 | 0.100 |
Why?
|
Neoplasms | 2 | 2018 | 22170 | 0.100 |
Why?
|
Congenital Abnormalities | 1 | 2017 | 709 | 0.100 |
Why?
|
Cesarean Section | 1 | 2020 | 1396 | 0.090 |
Why?
|
Leiomyoma | 1 | 2016 | 636 | 0.090 |
Why?
|
Choice Behavior | 1 | 2016 | 824 | 0.090 |
Why?
|
Germ Cells | 1 | 2014 | 634 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1521 | 0.090 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2016 | 1148 | 0.090 |
Why?
|
Tissue Survival | 2 | 2021 | 119 | 0.080 |
Why?
|
Androgens | 1 | 2016 | 1286 | 0.080 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2014 | 518 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.080 |
Why?
|
Adult | 9 | 2021 | 221177 | 0.080 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2164 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1420 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2017 | 1157 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4398 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2021 | 26198 | 0.060 |
Why?
|
Premature Birth | 1 | 2017 | 1782 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4244 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2016 | 3600 | 0.060 |
Why?
|
Morphine Derivatives | 1 | 2022 | 42 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4671 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8002 | 0.040 |
Why?
|
Fibrin | 1 | 2022 | 507 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5440 | 0.040 |
Why?
|
Intention | 1 | 2021 | 347 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 59243 | 0.040 |
Why?
|
Sheep | 1 | 2021 | 1440 | 0.040 |
Why?
|
Hysterectomy | 1 | 2022 | 857 | 0.040 |
Why?
|
Iran | 1 | 2020 | 737 | 0.040 |
Why?
|
Norpregnadienes | 1 | 2016 | 3 | 0.030 |
Why?
|
Estrenes | 1 | 2016 | 21 | 0.030 |
Why?
|
Intrauterine Devices, Medicated | 1 | 2016 | 26 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2021 | 2115 | 0.030 |
Why?
|
Levonorgestrel | 1 | 2016 | 74 | 0.030 |
Why?
|
Reproductive Health Services | 1 | 2016 | 87 | 0.030 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2016 | 132 | 0.030 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2016 | 155 | 0.030 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2016 | 116 | 0.030 |
Why?
|
Mifepristone | 1 | 2016 | 151 | 0.030 |
Why?
|
Curcumin | 1 | 2016 | 98 | 0.030 |
Why?
|
HELLP Syndrome | 1 | 2014 | 40 | 0.030 |
Why?
|
Oximes | 1 | 2016 | 303 | 0.030 |
Why?
|
Fetal Monitoring | 1 | 2014 | 69 | 0.030 |
Why?
|
Drugs, Chinese Herbal | 1 | 2016 | 144 | 0.030 |
Why?
|
Tea | 1 | 2016 | 288 | 0.030 |
Why?
|
Animals | 3 | 2021 | 168459 | 0.030 |
Why?
|
Mice | 1 | 2020 | 81525 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 64680 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1709 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 870 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1739 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 962 | 0.030 |
Why?
|
United States | 2 | 2017 | 72334 | 0.020 |
Why?
|
Adolescent | 2 | 2016 | 88319 | 0.020 |
Why?
|
Genital Neoplasms, Female | 1 | 2016 | 532 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8654 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2016 | 1129 | 0.020 |
Why?
|
Middle Aged | 4 | 2020 | 220895 | 0.020 |
Why?
|
Child | 1 | 2018 | 80153 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.020 |
Why?
|
Estradiol | 1 | 2016 | 1937 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26125 | 0.020 |
Why?
|
Cohort Studies | 2 | 2022 | 41487 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9646 | 0.020 |
Why?
|
Infant, Premature | 1 | 2017 | 2107 | 0.020 |
Why?
|
Vitamins | 1 | 2016 | 1635 | 0.020 |
Why?
|
Incidence | 2 | 2017 | 21353 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12059 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3808 | 0.020 |
Why?
|
Graft Survival | 1 | 2017 | 3819 | 0.020 |
Why?
|
Pre-Eclampsia | 1 | 2014 | 1231 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1896 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2016 | 2827 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2014 | 2024 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3688 | 0.010 |
Why?
|
Vitamin D | 1 | 2016 | 3303 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10773 | 0.010 |
Why?
|
Risk Factors | 2 | 2020 | 74206 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36192 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15842 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2016 | 21012 | 0.010 |
Why?
|